Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$6.48 USD
-0.21 (-3.14%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.47 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -1.20 |
EPS Last Quarter | -1.19 |
Last EPS Surprise | -3.48% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -4.64 |
Next Year | -3.68 |
EPS (TTM) | -7.08 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.10M | 0.15M | 0.27M | 0.35M |
# of Estimates | 2 | 2 | 3 | 2 |
High Estimate | 0.15M | 0.25M | 0.50M | 0.50M |
Low Estimate | 0.05M | 0.05M | 0.10M | 0.20M |
Year ago Sales | 0.39M | NA | 0.83M | 0.27M |
Year over Year Growth Est. | -74.36% | NA | -68.03% | 31.58% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.20 | -1.08 | -4.64 | -3.68 |
# of Estimates | 3 | 3 | 4 | 4 |
Most Recent Consensus | -1.12 | -1.05 | -4.64 | -3.66 |
High Estimate | -1.12 | -0.94 | -4.37 | -2.91 |
Low Estimate | -1.24 | -1.25 | -4.97 | -4.63 |
Year ago EPS | -1.08 | NA | -6.09 | -4.64 |
Year over Year Growth Est. | -11.11% | NA | 23.81% | 20.69% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 1 | 2 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.20 | -1.08 | -4.64 | -3.68 |
7 Days Ago | -1.20 | -1.08 | -4.64 | -3.68 |
30 Days Ago | -1.20 | -1.08 | -4.54 | -3.53 |
60 Days Ago | -1.14 | -1.09 | -4.50 | -3.16 |
90 Days Ago | -1.14 | -1.09 | -4.50 | -3.16 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.20 | -1.08 | -4.37 | -4.63 |
Zacks Consensus Estimate | -1.20 | -1.08 | -4.64 | -3.68 |
Earnings ESP | 0.00% | 0.00% | 5.77% | -25.90% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.19 | -1.31 | NA | -1.08 | NA |
Estimate | -1.15 | -1.08 | NA | -1.56 | NA |
Difference | -0.04 | -0.23 | NA | 0.48 | 0.07 |
Surprise | -3.48% | -21.30% | NA | 30.77% | 2.00% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more